Ashton Thomas Private Wealth’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$493K Buy
6,150
+3,243
+112% +$267K 0.01% 729
2025
Q4
$248K Buy
+2,907
New +$239K 0.01% 889
2024
Q3
Sell
-2,448
Closed -$226K 1000
2024
Q2
$226K Buy
2,448
+40
+2% +$3.54K 0.01% 541
2024
Q1
$230K Sell
2,408
-758
-24% -$63.7K 0.01% 552
2023
Q4
$241K Sell
3,166
-2,056
-39% -$143K 0.02% 529
2023
Q3
$362K Buy
5,222
+2,470
+90% +$198K 0.03% 452
2023
Q2
$260K Sell
2,752
-97
-3% -$8.43K 0.02% 509
2023
Q1
$236K Buy
2,849
+163
+6% +$12.8K 0.02% 455
2022
Q4
$200K Sell
2,686
-309
-10% -$23.8K 0.02% 457
2022
Q3
$247K Buy
2,995
+6
+0.2% +$577 0.03% 414
2022
Q2
$284K Sell
2,989
-4,653
-61% -$482K 0.03% 384
2022
Q1
$900K Sell
7,642
-219
-3% -$24.6K 0.08% 264
2021
Q4
$1.02M Buy
7,861
+591
+8% +$68.9K 0.1% 232
2021
Q3
$823K Buy
7,270
+673
+10% +$76.8K 0.12% 191
2021
Q2
$683K Sell
6,597
-2,866
-30% -$270K 0.1% 216
2021
Q1
$791K Sell
9,463
-936
-9% -$79.1K 0.13% 180
2020
Q4
$949K Buy
10,399
+2,240
+27% +$186K 0.18% 155
2020
Q3
$651K Buy
8,159
+4,297
+111% +$335K 0.16% 152
2020
Q2
$267K Buy
+3,862
New +$274K 0.08% 200

Other funds holding EW

Ashton Thomas Private Wealth's EW Position: Q1 2026 in Review

Ashton Thomas Private Wealth increased its Edwards Lifesciences (EW) stake by 112% in Q1 2026, buying an estimated $267K and bringing the position to 6,150 shares worth $493K. The position accounts for 0.01% of the portfolio, ranked #729.

Ashton Thomas Private Wealth first reported a position in EW in Q2 2020 and has held it in 19 quarters since. The position peaked at $1.02M in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Ashton Thomas Private Wealth held 6,150 shares of Edwards Lifesciences worth $493K as of Q1 2026.
  • Ashton Thomas Private Wealth bought 3,243 Edwards Lifesciences shares in Q1 2026, an estimated $267K.
  • Edwards Lifesciences made up 0.01% of Ashton Thomas Private Wealth's portfolio in Q1 2026, its #729 holding.
  • Ashton Thomas Private Wealth first reported a position in Edwards Lifesciences in Q2 2020 and has held it in 19 quarters since.
  • Ashton Thomas Private Wealth's Edwards Lifesciences position peaked at $1.02M in Q4 2021.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q1 2026, filed 11 May 2026.